Events / Exhibitions

Outline

Date

8th -11th June, 2026

Place

Budapest, Hungary

Our Booth

#96

Book meetings with us

Email to: labchem_wkeu@fujifilm.com

Visit our booth to learn more about our solutions for cancer research!

Our Showcase at EACR

Drug Discovery CRO Services

At FUJIFILM, we provide cutting-edge contract research services based on advanced research performed in Japan. We offer a comprehensive suite of highly customizable services globally for cancer research and more, such as:

• Custom Monoclonal Antibody Discovery
  using DNA immunization & Single B-Cell Screening
• drug2drugs AI-AAM^® - AI Drug Discovery
  For lead optimization of peptide & small molecule drugs
• h-iPS Derived Cell-Based Assay Services
  Custom assays for cardiotoxicity & neuroimmunology using Fujifilm iCell^® products

Cancer Cell Lines

The Japanese Collection of Research Bioresources(JCRB) Cell Bank offers one of the most comprehensive cell banks in the world for cancer and life sciences research, supplying researchers across many fields globally.

Our most popular cancer celllines:

• HuH-7 human hepatocellular carcinoma cell line
• Hep G2 hepatoblastoma-derived cell line
• HeLa cell lines...and much more!

Your Trusted Partner for Drug Discovery

Custom services with precision and expertise.

• AI Drug Discovery Service
• Custom Rabbit mAb Development
  Rabbit mAb Discovery using DNA Immunization and Single B-Cell Cloning Antibody Engineering & Optimization
• hiPS-derived Cell Based Assay Services
  Neurodegenerative and Neuroinflammation Disease Models Cardiotoxicity Testing
• New Therapeutic Modality
  Cyclic Peptide Discovery using mRNA Display System

Bridge the Clinical Gap with F-PDO^®

The next generation of patient-derived tumor organoids.

Why F-PDO^®?
Traditional cell lines fail to replicate clinical complexity. F-PDO^® (Fukushima Patient-Derived Tumor Organoids)

• LONG-TERM CULTURABILITY
  Engineered for sustained culturability while preserving the original tumor's structure and characteristics over extended passages.
• MULTI-OMIC VALIDATION
  Rigorously validated against source tissue via WES and gene expression profiling to ensure high fidelity to the patient's clinical profile.
• READY-TO-USE
  Available directly as frozen stocks or via our HTS-compatible contract research services for rapid drug sensitivity testing.
• DIVERSE LINEUP
  A robust library of strains covering 16+ cancer types, featuring specialized collections for lung (18), ovarian (10), and uterine (8) cancers.